Abstract
Adverse early life events can induce long-lasting changes in physiology and behavior. We found that early-life stress (ELS) in mice caused enduring hypersecretion of corticosterone and alterations in passive stress coping and memory. This phenotype was accompanied by a persistent increase in arginine vasopressin (AVP) expression in neurons of the hypothalamic paraventricular nucleus and was reversed by an AVP receptor antagonist. Altered Avp expression was associated with sustained DNA hypomethylation of an important regulatory region that resisted age-related drifts in methylation and centered on those CpG residues that serve as DNA-binding sites for the methyl CpG–binding protein 2 (MeCP2). We found that neuronal activity controlled the ability of MeCP2 to regulate activity-dependent transcription of the Avp gene and induced epigenetic marking. Thus, ELS can dynamically control DNA methylation in postmitotic neurons to generate stable changes in Avp expression that trigger neuroendocrine and behavioral alterations that are frequent features in depression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
03 December 2009
In the version of this article initially published, on page 2, left column, the phrase “…and typically cluster in glucocorticoid-rich regions called CpG islands (CGIs)” should be “…and typically cluster in GC-rich regions called CpG islands (CGIs)”. The error has been corrected in the HTML and PDF versions of the article.
References
Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33 Suppl, 245–254 (2003).
Jirtle, R.L. & Skinner, M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 8, 253–262 (2007).
Weaver, I.C. et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 7, 847–854 (2004).
Tsankova, N.M. et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9, 519–525 (2006).
Renthal, W. et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56, 517–529 (2007).
Flavell, S.W. & Greenberg, M.E. Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu. Rev. Neurosci. 31, 563–590 (2008).
Tsankova, N., Renthal, W., Kumar, A. & Nestler, E.J. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 8, 355–367 (2007).
Reik, W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447, 425–432 (2007).
McGowan, P.O. et al. Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS One 3, e2085 (2008).
McGowan, P.O. et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12, 342–348 (2009).
Fumagalli, F., Molteni, R., Racagni, G. & Riva, M.A. Stress during development: Impact on neuroplasticity and relevance to psychopathology. Prog. Neurobiol. 81, 197–217 (2007).
Gluckman, P.D., Hanson, M.A., Cooper, C. & Thornburg, K.L. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 359, 61–73 (2008).
de Kloet, E.R., Jöels, M. & Holsboer, F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6, 463–475 (2005).
Lupien, S.J., McEwen, B.S., Gunnar, M.R. & Heim, C. Effects of stress throughout the lifespan on the brain, behavior and cognition. Nat. Rev. Neurosci. 10, 434–445 (2009).
Levine, S. Developmental determinants of sensitivity and resistance to stress. Psychoneuroendocrinology 30, 939–946 (2005).
Charmandari, E., Tsigos, C. & Chrousos, G. Endocrinology of the stress response. Annu. Rev. Physiol. 67, 259–284 (2005).
Engelmann, M., Landgraf, R. & Wotjak, C.T. The hypothalamic-neurohypophysial system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Front. Neuroendocrinol. 25, 132–149 (2004).
Holmes, A., Heilig, M., Rupniak, N.M., Steckler, T. & Griebel, G. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol. Sci. 24, 580–588 (2003).
Serradeil-Le Gal, C. et al. An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders. CNS Drug Rev. 11, 53–68 (2005).
Aguilera, G. & Rabadan-Diehl, C. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul. Pept. 96, 23–29 (2000).
Meaney, M.J. Maternal care, gene expression and the transmission of individual differences in stress reactivity across generations. Annu. Rev. Neurosci. 24, 1161–1192 (2001).
Allis, C., Jenuwein, T. & Reinberg, D. Epigenetics (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2007).
Weber, M. et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 39, 457–466 (2007).
Gainer, H., Fields, R.L. & House, S.B. Vasopressin gene expression: experimental models and strategies. Exp. Neurol. 171, 190–199 (2001).
Suzuki, M.M. & Bird, A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 9, 465–476 (2008).
Belsham, D.D. et al. Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disorders. Endocrinology 145, 393–400 (2004).
Klose, R.J. et al. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell 19, 667–678 (2005).
Chen, W.G. et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302, 885–889 (2003).
Martinowich, K. et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302, 890–893 (2003).
Zhou, Z. et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth and spine maturation. Neuron 52, 255–269 (2006).
McGill, B.E. et al. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. USA 103, 18267–18272 (2006).
Malaspina, D. et al. Acute maternal stress in pregnancy and schizophrenia in offspring: a cohort prospective study. BMC Psychiatry 8, 71 (2008).
Bessa, J.M. et al. A trans-dimensional approach to the behavioral aspects of depression. Front. Behav. Neurosci. 3, 1 (2009).
Kalueff, A.V., Wheaton, M. & Murphy, D.L. What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav. Brain Res. 179, 1–18 (2007).
Cryan, J.F. & Slattery, D.A. Animal models of mood disorders: recent developments. Curr. Opin. Psychiatry 20, 1–7 (2007).
Chahrour, M. & Zoghbi, H.Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422–437 (2007).
Miller, C.A. & Sweatt, J.D. Covalent modification of DNA regulates memory formation. Neuron 53, 857–869 (2007).
Touma, C. et al. Mice selected for high versus low stress reactivity: a new animal model for affective disorders. Psychoneuroendocrinology 33, 839–862 (2008).
Müller, M.B. et al. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat. Neurosci. 6, 1100–1107 (2003).
Siegmund, A. & Wotjak, C.T. A mouse model of post-traumatic stress disorder that distinguishes between conditioned and sensitised fear. J. Psychiatr. Res. 41, 848–860 (2007).
Bächli, H., Steiner, M.A., Habersetzer, U. & Wotjak, C.T. Increased water temperature renders single-housed C57BL/6J mice susceptible to antidepressant treatment in the forced swim test. Behav. Brain Res. 187, 67–71 (2008).
Patchev, A.V. et al. Insidious adrenocortical insufficiency underlies neuroendocrine dysregulation in TIF-2 deficient mice. FASEB J. 21, 231–238 (2007).
Hoffmann, A. et al. Transcriptional activities of the zinc finger protein Zac are differentially controlled by DNA binding. Mol. Cell. Biol. 23, 988–1003 (2003).
Fields, R.L., House, S.B. & Gainer, H. Regulatory domains in the intergenic region of the oxytocin and vasopressin genes that control their hypothalamus-specific expression in vitro. J. Neurosci. 23, 7801–7809 (2003).
Kriaucionis, S. & Bird, A. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res. 32, 1818–1823 (2004).
Fuks, F. et al. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278, 4035–4040 (2003).
Ghoshal, K. et al. Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression. J. Biol. Chem. 279, 6783–6793 (2004).
Hanson, P.I., Meyer, T., Stryer, L. & Schulman, H. Dual role of calmodulin in autophosphorylation of multifunctional CaM kinase may underlie decoding of calcium signals. Neuron 12, 943–956 (1994).
Murgatroyd, C. et al. Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety. J. Neurosci. 24, 7762–7770 (2004).
Barz, T., Hoffmann, A., Panhuysen, M. & Spengler, D. Peroxisome proliferator- activated receptor gamma is a Zac target gene mediating Zac antiproliferation. Cancer Res. 66, 11975–11982 (2006).
Acknowledgements
We thank A. Hoffmann and R. Stoffel for their excellent technical assistance, A. Varga and B. Wörle for help with animal care, N. Sousa, J.-P. Schülke, T. Bettecken, F. Roselli and R. Spanagel for support. We thank S. Aventis for supplying SSR149415. This work was funded by the European Union (CRESCENDO – European Union contract number LSHM-CT-2005-018652 to O.F.X.A. and D.S.) and the Deutsche Forschungsgemeinschaft (SP 386/4-2 to D.S.).
Author information
Authors and Affiliations
Contributions
The study was conceived and designed by D.S. and O.F.X.A. C.M. and D.S. designed and interpreted the molecular studies that were carried out by C.M., Y.W., Y.B. and D.F., A.V.P. and O.F.X.A. were responsible for the neuroendocrine studies and A.V.P. and V.M. carried out the behavioral experiments under the guidance of C.T.W. C.M., A.V.P., F.H., O.F.X.A. and D.S. wrote the paper, with input from all of the other authors.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–11 and Supplementary Tables 1–4 (PDF 1409 kb)
Rights and permissions
About this article
Cite this article
Murgatroyd, C., Patchev, A., Wu, Y. et al. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 12, 1559–1566 (2009). https://doi.org/10.1038/nn.2436
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.2436
This article is cited by
-
Investigating the effects of maltreatment and acute stress on the concordance of blood and DNA methylation methods of estimating immune cell proportions
Clinical Epigenetics (2023)
-
Reflections from the former Chief Editors of Nature Neuroscience
Nature Neuroscience (2023)
-
Molecular pathways of major depressive disorder converge on the synapse
Molecular Psychiatry (2023)
-
Methyl-CpG binding protein 2 expression is associated with symptom severity in patients with PTSD in a sex-dependent manner
Translational Psychiatry (2023)
-
Interaction of the pre- and postnatal environment in the maternal immune activation model
Discover Mental Health (2023)